Director/PDMR Shareholding

RNS Number : 5706T

GlaxoSmithKline PLC

06 October 2014

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 6 October 2014, of changes in the interests of the following Directors and Persons Discharging Managerial Responsibility, following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs), at a price of 1414.00 pence per Ordinary Share and $45.90 per ADS, following the re-investment of dividends paid on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	1,994	1,994
Mr S Dingemans	877	877
Mr S M Bicknell	199	199
Mr R G Connor	224	224
Mr S A Hussain	113	113
Mr D S Redfern	426	426
Ms C Thomas	322	322
Mr P C Thomson	65	65
Dr P J T Vallance	935	935
Ms E Walmsley	516	516

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	816	816
Mrs D P Connelly	157	157
Mr W C Louv	197	197
Mr D E Troy	361	361

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant measurement period.

V A Whyte

Company Secretary

6 October 2014

 

END

 

 

RDSZQLFBZBFXFBD